This class of drug is meant to interfere with the entry, fusion or binding of the HIV virus to a healthy cell.
DHHS Status: Not recommended, other
FDA approval date: August 7, 2006
Financial Assistance: https://www.viivhealthcareforyou.com
Selzentry is available in 150 and 300mg tablets, and must be taken twice a day. There is no “standard” dose for Selzentry. The dosing varies depending on which other medications you take with it.
Review: Selzentry is the first in the class of entry inhibitors. It stops HIV from entering your cells using the CCR5 receptor. Unfortunately, it does not work against strains of the virus that use another receptor called CXCR4. You should have a “tropism assay” done before taking Selzentry to see if the drug will work for you. This testing is expensive but there can be financial assistance available through ViiV.
Copyright 2017, Positive Health Publications, Inc.
This magazine is intended to enhance your relationship with your doctor - not replace it! Medical treatments and products should always be discussed with a licensed physician who has experience treating HIV and AIDS!